1. X12 Public Comment Period Timeline for X12N 7030™ Technical Reports

    X12's Insurance Subcommittee (X12N) has determined the schedule for the next public review and comment periods related to the 007030 counterparts to the HIPAA-adopted transactions and related Type 3 Technical Reports (TR3s).

    Read More

  2. NLM Adds Prescribable Names to RxNorm

    The National Library of Medicine (NLM) is delighted to announce that the April 2017 RxNorm monthly release contains Prescribable Names (TTY=PSN) for all RxNorm normal forms for active human drugs sold in the United States (US) with a few exceptions.

    Drugs without PSNs include allergenic extracts and certain forms containing three or more ingredients. Prescribable names are user-friendly synonyms of RxNorm SCD/SBD/GPCK/BPCK concepts and are meant to be used as display names in ePrescribing systems. Unlike other RxNorm synonyms (TTY=SY and TTY=TMSY), there can only be a single prescribable name associated with an RxNorm concept (i.e., RXCUI). RxNorm editors create prescribable names based upon the drug packaging in the Structured Product Labels (SPLs) on DailyMed (https://dailymed.nlm.nih.gov/).

    Read More

  3. Learn About NCPDP’s PDMP Solution

    NCPDP’s Interoperable PDMP Solution is our highest strategic priority. Our model solution can help address the opioid epidemic by fortifying state PDMPs (Prescription Drug Monitoring Programs). The solution leverages best practices and existing industry standards to ensure access for patients with a valid medical need while averting potential fraud and abuse.
     

    Read More

  4. Pilot of NCPDP Pharmacist Care Plan Announced

    The joint NCPDP-HL7 Pharmacist Care Plan C-CDA is the subject of an Office of the National Coordinator for Health Information Technology (ONCHigh Impact Pilot (HIP) being initiated through partnership with Community Care of North Carolina (CCNC) using funding from the Centers for Medicare and Medicaid Innovation (CMMI) to test new reimbursement models for community pharmacies serving Medicaid, Medicare, dually eligible, and NC Health Choice beneficiaries. Six vendors are participating in the pilot covering services to a population of over three million Medicaid, Medicare, and dual-eligible beneficiaries. To read the press release announcing the pilot, click here.

    Read More

  5. Billing Unit Change to ProstaScint®

    PROSTASCINT® Kit for the Preparation of Indium In 111 Capromab Pendetide (NDC 57902-0817-010) currently listed with a billing unit of “each”, will be listed with a billing unit of “ML” by the Drug Compendia effective with each compendium’s quarterly release update files for the end of September 2016 or the start of October 2016. Please contact your drug compendia to obtain the specific date of their file change. This change in billing unit conforms with the NCPDP Billing Unit Standard (Section 5.2.2 and 5.2.9). 

    Read More

For problems with the site please contact us at webmaster@ncpdp.org